Zhejiang Jolly Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.007x

Zhejiang Jolly Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-23.58 Million ≈ $-3.45 Million USD) by net assets (CN¥3.18 Billion ≈ $465.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)

Cash flow conversion efficiency of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025. This chart illustrates how Zhejiang Jolly Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300181 stock price for real-time trading data and today's change.

Zhejiang Jolly Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Zhejiang Jolly Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhejiang Jolly Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Jolly Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Zhejiang Jolly Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Kontron AG VI:KTN	-0.006x
Teva Pharmaceutical Industries Ltd TA:TEVA	0.093x
Syndax Pharmaceuticals Inc NASDAQ:SNDX	-2.005x
Liberty Global PLC Class C NASDAQ:LBTYK	0.024x
La-Z-Boy Incorporated NYSE:LZB	0.085x
ATAI Life Sciences NV XETRA:9VC	-0.145x
Guangzhou Restaurants Group Co SHG:603043	0.243x
Inter & Co. Inc. Class A Common Shares NASDAQ:INTR	0.119x

Annual Cash Flow Conversion Efficiency for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025. Review 300181 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.24 Billion ≈ $474.31 Million	CN¥411.80 Million ≈ $60.26 Million	0.127x	+20.59%
2024-12-31	CN¥2.82 Billion ≈ $412.57 Million	CN¥297.05 Million ≈ $43.47 Million	0.105x	+1.31%
2023-12-31	CN¥2.77 Billion ≈ $405.92 Million	CN¥288.46 Million ≈ $42.21 Million	0.104x	-9.91%
2022-12-31	CN¥2.76 Billion ≈ $403.86 Million	CN¥318.59 Million ≈ $46.62 Million	0.115x	-9.08%
2021-12-31	CN¥1.98 Billion ≈ $290.21 Million	CN¥251.80 Million ≈ $36.85 Million	0.127x	-21.95%
2020-12-31	CN¥1.72 Billion ≈ $251.61 Million	CN¥279.69 Million ≈ $40.93 Million	0.163x	+77.59%
2019-12-31	CN¥1.41 Billion ≈ $206.00 Million	CN¥128.94 Million ≈ $18.87 Million	0.092x	+62.31%
2018-12-31	CN¥1.39 Billion ≈ $203.01 Million	CN¥78.28 Million ≈ $11.46 Million	0.056x	+1192.59%
2017-12-31	CN¥1.49 Billion ≈ $218.09 Million	CN¥6.51 Million ≈ $952.09K	0.004x	-88.98%
2016-12-31	CN¥1.47 Billion ≈ $215.38 Million	CN¥58.30 Million ≈ $8.53 Million	0.040x	-41.45%
2015-12-31	CN¥1.44 Billion ≈ $210.07 Million	CN¥97.13 Million ≈ $14.21 Million	0.068x	+330.67%
2014-12-31	CN¥871.76 Million ≈ $127.57 Million	CN¥13.70 Million ≈ $2.00 Million	0.016x	-58.87%
2013-12-31	CN¥772.52 Million ≈ $113.04 Million	CN¥29.50 Million ≈ $4.32 Million	0.038x	-11.63%
2012-12-31	CN¥705.92 Million ≈ $103.30 Million	CN¥30.51 Million ≈ $4.46 Million	0.043x	+116.47%
2011-12-31	CN¥683.92 Million ≈ $100.08 Million	CN¥13.65 Million ≈ $2.00 Million	0.020x	-93.61%
2010-12-31	CN¥207.17 Million ≈ $30.32 Million	CN¥64.78 Million ≈ $9.48 Million	0.313x	+18.04%
2009-12-31	CN¥165.70 Million ≈ $24.25 Million	CN¥43.89 Million ≈ $6.42 Million	0.265x	+26.77%
2008-12-31	CN¥149.11 Million ≈ $21.82 Million	CN¥31.16 Million ≈ $4.56 Million	0.209x	+88.11%
2007-12-31	CN¥144.47 Million ≈ $21.14 Million	CN¥16.05 Million ≈ $2.35 Million	0.111x	--

About Zhejiang Jolly Pharmaceutical Co Ltd

SHE:300181 China Drug Manufacturers - General

Market Cap

$1.28 Billion

CN¥8.72 Billion CNY

Market Cap Rank

#7608 Global

#1614 in China

Share Price

CN¥12.43

Change (1 day)

+1.30%

52-Week Range

CN¥12.00 - CN¥18.45

All Time High

CN¥20.53